- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
23 Multiple Sclerosis Trials near Dallas, TX
Power is an online platform that helps thousands of Multiple Sclerosis patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerFrexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
1400 Participants Needed
Remibrutinib vs Teriflunomide for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
800 Participants Needed
Trial Details
Key Eligibility Criteria
129 Participants Needed
Trial Details
Key Eligibility Criteria
156 Participants Needed
Remibrutinib vs Teriflunomide for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
800 Participants Needed
High-Dose Ocrelizumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
769 Participants Needed
Ozanimod for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
250 Participants Needed
Ublituximab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
1100 Participants Needed
Ocrelizumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
123 Participants Needed
Cladribine After Natalizumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
40 Participants Needed
Cladribine for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
47 Participants Needed
Trial Details
Key Eligibility Criteria
180 Participants Needed
Gold Nanocrystals for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
30 Participants Needed
Light Therapy for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
20 Participants Needed
Trial Details
Key Eligibility Criteria
900 Participants Needed
CC-97540 for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
120 Participants Needed
Nivolumab for Cancer
Trial Details
Key Eligibility Criteria
300 Participants Needed
Frexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
858 Participants Needed
Trial Details
Key Eligibility Criteria
100 Participants Needed
Obexelimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
93 Participants Needed
Why Other Patients Applied
"I am 42 yrs old with 2 little kids, work as a nurse, tried several drugs, most made me feel awful. I want my quality of life. I don’t want to have to take something daily/monthly. I don’t like the side effects of many drugs. I'm excited to be considered as a candidate for one of these trials."
"I've tried 2 MS drugs but I am getting worse. I am having trouble walking long distances or for more than 30 minutes. I need to find a new medication. My doctor and I discussed some of the options in trials and I'm ready to dive in to learn more."
"I've been battling multiple sclerosis for 28 years. I've tried three medications. I keep my dosing stable, but I'm just tired of managing. I want to take control of my situation."
"I've been taking Kesimpta for a couple years now and seem to be having more flare ups. I'm only 43. I have 5 kids and feel like I'm missing my life. Sleeping my life away. I'm ready to try ANYTHING for a chance at living life again."
"I've been using natural supplements and would like to find something more effective. My former PCP was hesitant to prescribe modafanil. I'm interested in learning about all options available to me—including the drugs currently under research investigation."
Ofatumumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
562 Participants Needed
Fenebrutinib for Relapsing Multiple Sclerosis
Trial Details
Key Eligibility Criteria
746 Participants Needed
Ocrelizumab vs Fingolimod for Pediatric Multiple Sclerosis
Trial Details
Key Eligibility Criteria
171 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.